Potential Economic Viability of Two Proposed Rifapentine-Based Regimens for Treatment of Latent Tuberculosis Infection

RATIONALE: Rifapentine-based regimens for treating latent tuberculosis infection (LTBI) are being considered for future clinical trials, but even if they prove effective, high drug costs may limit their economic viability. OBJECTIVES: To inform clinical trial design by estimating the potential costs...

Descripción completa

Detalles Bibliográficos
Autores principales: Holland, David P., Sanders, Gillian D., Hamilton, Carol D., Stout, Jason E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138781/
https://www.ncbi.nlm.nih.gov/pubmed/21789248
http://dx.doi.org/10.1371/journal.pone.0022276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138781/
https://www.ncbi.nlm.nih.gov/pubmed/21789248
http://dx.doi.org/10.1371/journal.pone.0022276

Ejemplares similares